NCT00486200View on ClinicalTrials.gov

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

PHASE2CompletedINTERVENTIONAL
Enrollment

695

Participants

Timeline

Start Date

June 21, 2007

Primary Completion Date

August 12, 2008

Study Completion Date

August 12, 2008

Conditions
Herpes Genitalis
Interventions
DRUG

ASP2151

Oral administration.

DRUG

valacyclovir

Oral administration of active comparator.

DRUG

Placebo

Oral administration of placebo.

Trial Locations (25)

19103

Philadelphia

21201

Baltimore

22003

Annandale

30328

Atlanta

33156

Miami

33472

Boynton Beach

35294

Birmingham

42431

Madisonville

46202

Indianapolis

59101

Billings

68134

Omaha

76011

Arlington

77030

Houston

77058

Houston

80262

Denver

84132

Salt Lake City

85015

Phoenix

85712

Tucson

87131

Albuquerque

90017

Los Angeles

91361

Westlake Village

92108

San Diego

95821

Sacramento

97210

Portland

98122

Seattle

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY